SE9501285L - Process for producing biologically active proteins - Google Patents
Process for producing biologically active proteinsInfo
- Publication number
- SE9501285L SE9501285L SE9501285A SE9501285A SE9501285L SE 9501285 L SE9501285 L SE 9501285L SE 9501285 A SE9501285 A SE 9501285A SE 9501285 A SE9501285 A SE 9501285A SE 9501285 L SE9501285 L SE 9501285L
- Authority
- SE
- Sweden
- Prior art keywords
- biologically active
- active proteins
- producing biologically
- producing
- proteins
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9501285A SE9501285L (en) | 1995-04-06 | 1995-04-06 | Process for producing biologically active proteins |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9501285A SE9501285L (en) | 1995-04-06 | 1995-04-06 | Process for producing biologically active proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
SE9501285D0 SE9501285D0 (en) | 1995-04-06 |
SE9501285L true SE9501285L (en) | 1996-10-07 |
Family
ID=20397877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9501285A SE9501285L (en) | 1995-04-06 | 1995-04-06 | Process for producing biologically active proteins |
Country Status (1)
Country | Link |
---|---|
SE (1) | SE9501285L (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8716240B2 (en) | 2001-10-10 | 2014-05-06 | Novo Nordisk A/S | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US8791066B2 (en) | 2004-07-13 | 2014-07-29 | Novo Nordisk A/S | Branched PEG remodeling and glycosylation of glucagon-like peptide-1 [GLP-1] |
US8841439B2 (en) | 2005-11-03 | 2014-09-23 | Novo Nordisk A/S | Nucleotide sugar purification using membranes |
US8853161B2 (en) | 2003-04-09 | 2014-10-07 | Novo Nordisk A/S | Glycopegylation methods and proteins/peptides produced by the methods |
US8911967B2 (en) | 2005-08-19 | 2014-12-16 | Novo Nordisk A/S | One pot desialylation and glycopegylation of therapeutic peptides |
US8916360B2 (en) | 2003-11-24 | 2014-12-23 | Novo Nordisk A/S | Glycopegylated erythropoietin |
US8969532B2 (en) | 2006-10-03 | 2015-03-03 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography |
US9005625B2 (en) | 2003-07-25 | 2015-04-14 | Novo Nordisk A/S | Antibody toxin conjugates |
US9187532B2 (en) | 2006-07-21 | 2015-11-17 | Novo Nordisk A/S | Glycosylation of peptides via O-linked glycosylation sequences |
US9187546B2 (en) | 2005-04-08 | 2015-11-17 | Novo Nordisk A/S | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
US9200049B2 (en) | 2004-10-29 | 2015-12-01 | Novo Nordisk A/S | Remodeling and glycopegylation of fibroblast growth factor (FGF) |
US9493499B2 (en) | 2007-06-12 | 2016-11-15 | Novo Nordisk A/S | Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7173003B2 (en) | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
EP1858543B1 (en) | 2005-01-10 | 2013-11-27 | BioGeneriX AG | Glycopegylated granulocyte colony stimulating factor |
CN101796063B (en) | 2007-04-03 | 2017-03-22 | 拉蒂奥法姆有限责任公司 | methods of treatment using glycopegylated G-CSF |
-
1995
- 1995-04-06 SE SE9501285A patent/SE9501285L/en not_active Application Discontinuation
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8716240B2 (en) | 2001-10-10 | 2014-05-06 | Novo Nordisk A/S | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US8853161B2 (en) | 2003-04-09 | 2014-10-07 | Novo Nordisk A/S | Glycopegylation methods and proteins/peptides produced by the methods |
US9005625B2 (en) | 2003-07-25 | 2015-04-14 | Novo Nordisk A/S | Antibody toxin conjugates |
US8916360B2 (en) | 2003-11-24 | 2014-12-23 | Novo Nordisk A/S | Glycopegylated erythropoietin |
US8791066B2 (en) | 2004-07-13 | 2014-07-29 | Novo Nordisk A/S | Branched PEG remodeling and glycosylation of glucagon-like peptide-1 [GLP-1] |
US10874714B2 (en) | 2004-10-29 | 2020-12-29 | 89Bio Ltd. | Method of treating fibroblast growth factor 21 (FGF-21) deficiency |
US9200049B2 (en) | 2004-10-29 | 2015-12-01 | Novo Nordisk A/S | Remodeling and glycopegylation of fibroblast growth factor (FGF) |
US9187546B2 (en) | 2005-04-08 | 2015-11-17 | Novo Nordisk A/S | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
US8911967B2 (en) | 2005-08-19 | 2014-12-16 | Novo Nordisk A/S | One pot desialylation and glycopegylation of therapeutic peptides |
US8841439B2 (en) | 2005-11-03 | 2014-09-23 | Novo Nordisk A/S | Nucleotide sugar purification using membranes |
US9187532B2 (en) | 2006-07-21 | 2015-11-17 | Novo Nordisk A/S | Glycosylation of peptides via O-linked glycosylation sequences |
US8969532B2 (en) | 2006-10-03 | 2015-03-03 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography |
US9493499B2 (en) | 2007-06-12 | 2016-11-15 | Novo Nordisk A/S | Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography |
Also Published As
Publication number | Publication date |
---|---|
SE9501285D0 (en) | 1995-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69631903D1 (en) | DISCRETE COUNTER-CHROMATOGRAPHY PROCESS | |
FI973543A0 (en) | Process for the preparation of heteromultimeric polypeptides | |
NO982991D0 (en) | Growth hormone-sekretagoguer | |
FI960278A (en) | Process for the preparation of anatastitanium dioxide | |
DE69620107D1 (en) | crystallization process | |
SE9501285L (en) | Process for producing biologically active proteins | |
NO974169D0 (en) | Process for tetra-azacycloalkane preparation | |
EP0816510A4 (en) | Process for producing biologically active fused proteins | |
FI961378A (en) | Process for Preparation of N-Methyl-3- (1-methyl-4-piperidinyl) -14-indole-5-ethanesulfonamide | |
FI964229A0 (en) | Process for the preparation of doxorubicin | |
EE03440B1 (en) | Biologically active benzothiazolone ethanamines and process for their preparation | |
DE69735180D1 (en) | Software update process | |
FI973105A0 (en) | Process for Preparation of (4,10-Diacetoxy-2alpha-benzoylloxy-5beta, 20epoxy-1,7beta-dihydroxy-9-oxotax-11-en-13alpha-yl) - (2R, 3S) -3-benzoylamino-3- phenyl-2-hydroxipropionaattrihydrat | |
FI956153A (en) | Process for making white liquor | |
KR970006251A (en) | Manufacturing method of high protein organic fertilizer | |
FI974002A0 (en) | Process for the preparation of Form 1 ranitidine hydrochloride | |
ITRM960874A0 (en) | IMPROVED PROCESS FOR THE PRODUCTION OF 5-HYDROXYMETHYLTHIAZOLE | |
FI97725B (en) | Process for the preparation of diltiazem | |
FI973341A (en) | Process for the preparation of organosilanes | |
FI943660A (en) | Preparation Process for 3-Carbonylandrostadien-17-Carboxamides | |
FR2768308B1 (en) | PROCESS FOR PRODUCING PROTEIN GEL | |
FI950751A0 (en) | Process for producing olefins | |
FI97745B (en) | Support means and method for manufacturing the support means | |
FI951441A (en) | Process for the preparation of 5-formylamino-pyrimidines | |
SE9501550D0 (en) | Process for making transport unit and transport unit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |